ITALY | WP5 | |||
Organization | University of Padova (UNIPD) | |||
Name of cohort | PADOVA | |||
Referring partner | UNIVR | |||
Cohort Information | Country(-ies), cities, regions or centers involved | Padova, Italy | ||
Time of data collection | 12/2020 | Ongoing | ||
Enrolment | Inactive | |||
Study setting | Single center | |||
Population | Age | Adults | ||
Type | Retrospective | |||
Total number of patients | 6208 | |||
Data collection | Clinical data | True | ||
Serological data | True | |||
Genetic data | False | |||
Sample collection | True | |||
Sample collected | Whole blood | Yes | ||
PBMC | No | |||
Dry-spot blood | No | |||
Plasma | No | |||
Serum | No | |||
Stool | No | |||
NP swabs | Yes | |||
Other | Salivary swabs | |||
Description | The cohort consists of over six thousand healthcare workers from the University Hospital of Padova, stratified by gender, age and job title. The subjects are vaccinated against SARS-CoV-2 and periodically tested with nasopharyngeal or salivary swabs. Subjects were also tested once with serology test between 1-3 months after the third dose of SARS-CoV-2 vaccine (approximately 1 year after the first dose). Clinical data were collected via online questionnaire. |